Skip to main content

Seizures clinical trials at UC Davis
1 research study open to eligible people

  • A Study of the Safety and Effectiveness of Experimental Perampanel For Partial Onset Seizures

    open to eligible people ages 4 years and up

    This study will assess the retention rate of perampanel when given as monotherapy or first adjunctive therapy in participants with partial-onset seizures or primary generalized tonic clonic seizures. The study consists of 4 periods: a Screening Period (to start no earlier than 6 weeks before the first dose of study drug), a Titration Period (up to 13 weeks), a Maintenance Period (39 weeks), and a Follow-Up Period (4 weeks).

    Sacramento, California and other locations

Last updated: